UBS Group AG Sells 40,641 Shares of BlackRock Health Sciences Term Trust $BMEZ

UBS Group AG trimmed its stake in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 3.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,034,791 shares of the company’s stock after selling 40,641 shares during the quarter. UBS Group AG’s holdings in BlackRock Health Sciences Term Trust were worth $15,574,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently made changes to their positions in BMEZ. Baird Financial Group Inc. bought a new position in shares of BlackRock Health Sciences Term Trust during the first quarter worth about $189,000. Geneos Wealth Management Inc. acquired a new stake in BlackRock Health Sciences Term Trust in the first quarter valued at approximately $40,000. NewEdge Advisors LLC grew its stake in BlackRock Health Sciences Term Trust by 134.3% in the second quarter. NewEdge Advisors LLC now owns 48,300 shares of the company’s stock valued at $689,000 after acquiring an additional 27,686 shares during the period. Jane Street Group LLC grew its stake in BlackRock Health Sciences Term Trust by 157.1% in the second quarter. Jane Street Group LLC now owns 97,472 shares of the company’s stock valued at $1,390,000 after acquiring an additional 59,559 shares during the period. Finally, Ameriprise Financial Inc. boosted its position in shares of BlackRock Health Sciences Term Trust by 14.0% during the second quarter. Ameriprise Financial Inc. now owns 14,521 shares of the company’s stock valued at $212,000 after buying an additional 1,787 shares during the last quarter.

BlackRock Health Sciences Term Trust Stock Up 0.8%

Shares of NYSE:BMEZ opened at $14.28 on Thursday. The business’s 50 day moving average is $14.27 and its 200 day moving average is $14.83. BlackRock Health Sciences Term Trust has a 12-month low of $13.67 and a 12-month high of $15.80.

BlackRock Health Sciences Term Trust Dividend Announcement

The company also recently announced a monthly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Monday, June 15th will be paid a $0.11 dividend. The ex-dividend date is Monday, June 15th. This represents a c) annualized dividend and a dividend yield of 9.2%.

BlackRock Health Sciences Term Trust Profile

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.